Advancing Healthcare Solutions
Global Manufacturing Powerhouse
Committed to Top-Notch Quality
Our stringent 100% quality control ensures that every product meets global standards. We exceed compliance with ISO, ESG, IGBC, and GMP certifications—all supported by in-house 21-CFR-compliant systems.
Robust Intellectual Property Portfolio
Proprietary methods, specialised machines, and drug delivery techniques ensure precision and innovation in targeted and programmed drug delivery.
Converting concepts into reality
Discover Concept Medical
Envision Scientific leads the field in manufacturing drug-eluting stents (DES) and drug-coated balloons (DCB) using proprietary processes and technology. We deliver some of the most challenging drugs via proprietary drug delivery technologies.
We offer DES and DCB solutions for cardiovascular, peripheral, erectile dysfunction, and arterio-venous fistula treatments.
Press Articles
The “MAGICAL BTK” (Randomized Controlled Trial of MagicTouch PTA – Sirolimus Coated Balloon Versus Standard Balloon Angioplasty in the Treatment of Below The Knee arterial disease) U.S. Investigational Device Exemption (IDE) pivotal trial. The first patient was enrolled by Dr. Prakash Krishnan, MD, and his team at the Icahn School of Medicine at Mount Sinai, marking a crucial milestone in the advancement of treatment options for patients suffering from peripheral artery disease (PAD) below the knee.
The SirPAD (Major adverse limb events in patients with femoro-popliteal and below-the-knee peripheral arterial disease treated with either sirolimus-coated or uncoated balloon) randomised controlled trial is the world’s largest study evaluating the treatment of Peripheral Artery Disease (PAD) using the MagicTouch PTA Sirolimus Coated Balloon (Concept Medical Inc.) versus uncoated balloons and one of the largest device studies ever performed for PAD.